ADAMTS1 and neoplasm: Immunoblot results confirmed the higher levels of CD147, ADAMTS1 and 9 expression in tumor lysates from mice with n-siRNA than those from mice with CD147-siRNA, demonstrating the successful silencing of CD147 and downstream ADAMTSs in vivo (Figure 5F).